AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on U.S. investments
By Maggie Fick and Yadarisa Shabong (Reuters) -Drugmaker AstraZeneca (NASDAQ:AZN) lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong demand for…